GenoGenix LLC recalls NAD+ (Nicotinamide adenine dinucleotide) for Injection, a) 100 mg/mL b) 200 mg/mL, 10 mL multi-dose amber vials, GenoGen
Recalled October 15, 2025 · FDA recall D-0094-2026 · GenoGenix
Hazard
Microbial Contamination of Sterile Products: elevated endotoxin levels · FDA Class I
Sold at
US Nationwide.
Description
Microbial Contamination of Sterile Products: elevated endotoxin levels
Product
NAD+ (Nicotinamide adenine dinucleotide) for Injection, a) 100 mg/mL b) 200 mg/mL, 10 mL multi-dose amber vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.
Manufacturer(s)
GenoGenix LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →